• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

    12/6/23 8:32:03 AM ET
    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACRS alert in real time by email

    Shares of SentinelOne, Inc. (NYSE:S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.

    SentinelOne reported third-quarter revenue of $164.2 million, beating the analyst consensus estimate of $156.09 million. The company also reported an adjusted loss of 3 cents per share, beating the analyst consensus estimate of a loss of 8 cents per share, according to Benzinga Pro.

    The company raised the full-year 2024 revenue outlook from $605 million to $616 million.

    SentinelOne shares gained 18.6% to $23.71 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Clean Earth Acquisitions Corp. (NASDAQ:CLIN) shares gained 105.5% to $12.64 in pre-market trading after falling over 3% on Tuesday.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) shares rose 78.7% to $0.4109 in pre-market trading after the company announced it raised $2.5 million in debt financing.
    • Dune Acquisition Corporation (NASDAQ:DUNE) rose 23.8% to $6.08 in pre-market trading after dipping over 15% on Tuesday.
    • Bit Brother Limited (NASDAQ:BETS) gained 23.5% to $0.0414 in pre-market trading. Bit Brother shares fell over 51% on Tuesday after the company announced the pricing of a $12 million registered direct offering.
    • Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 19.6% to $1.18 in pre-market trading. Aclaris Therapeutics announced exclusive patent license agreement with Sun Pharma for rights of deuruxolitinib.
    • Meiwu Technology Company Limited (NASDAQ:WNW) shares surged 17.1% to $0.0937 in pre-market trading after gaining 11% on Tuesday.
    • Phio Pharmaceuticals Corp. (NASDAQ:PHIO) shares rose 17% to $1.31 in pre-market trading.
    • Mobiv Acquisition Corp (NASDAQ:MOBV) gained 16.4% to $5.82 in pre-market trading after gaining 5% on Tuesday.
    • Aspen Aerogels, Inc. (NYSE:ASPN) shares climbed 12.7% to $12.00 in pre-market trading. Aspen Aerogels reported additional EV Thermal barrier commercial award and issued an update on U.S. Department of Energy loan application status.

    Losers

    • ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) dipped 28.6% to $1.10 in pre-market trading after reporting a proposed public offering of common shares.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares fell 16.7% to $0.94 in pre-market trading after declining 24% on Tuesday. The company announced that it met its primary safety, tolerability and secondary clinical efficacy endpoints in its Phase 2b PARADIGM Trial of PrimeC in ALS.
    • Yext, Inc. (NYSE:YEXT) shares fell 15.6% to $5.92 in pre-market trading after the company reported third-quarter financial results and issued guidance.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares fell 13.7% to $0.50 in pre-market trading. Allarity recently announced initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of stenoparib in women with advanced ovarian cancer.
    • Asana, Inc. (NYSE:ASAN) shares fell 13.4% to $20.19 in pre-market trading. Asana posted upbeat results for its third quarter and issued a strong forecast for FY24.
    • Box, Inc. (NYSE:BOX) fell 13% to $23.22 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 guidance below estimates.
    • Abits Group Inc. (NASDAQ:ABTS) shares fell 12% to $1.10 in pre-market trading after jumping 19% on Tuesday.
    • Nxu, Inc. (NASDAQ:NXU) fell 11.8% to $0.0225 in pre-market trading after declining more than 6% on Tuesday. NXU named Sarah Wyant as interim CFO, succeeding Apoorv Dwivedi.
    • Better Choice Company Inc. (NYSE:BTTR) fell 11.3% to $0.3236 in pre-market trading after gaining over 5% on Tuesday.
    • Janover Inc. (NASDAQ:JNVR) fell 8.1% to $1.49 in pre-market after surging 38% on Tuesday.

     

    Now Read This: Campbell Soup, SentinelOne And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ACRS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRS
    $ALLR
    $ASAN
    $ASPN

    CompanyDatePrice TargetRatingAnalyst
    Yext Inc.
    $YEXT
    3/11/2026$6.00Buy → Neutral
    Roth Capital
    SentinelOne Inc.
    $S
    3/3/2026$13.00Equal Weight
    Wells Fargo
    Asana Inc.
    $ASAN
    1/15/2026$16.00Neutral → Buy
    Citigroup
    SentinelOne Inc.
    $S
    1/5/2026$17.00Overweight → Neutral
    Piper Sandler
    Asana Inc.
    $ASAN
    12/17/2025Neutral
    BTIG Research
    Asana Inc.
    $ASAN
    12/15/2025$18.00Sector Weight → Overweight
    KeyBanc Capital Markets
    SentinelOne Inc.
    $S
    11/18/2025$25.00Buy
    Berenberg
    Box Inc.
    $BOX
    9/18/2025$36.00Neutral
    UBS
    More analyst ratings

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SentinelOne Inc.

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    3/10/26 6:15:28 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    President, CEO Weingarten Tomer sold $510,068 worth of shares (36,932 units at $13.81), decreasing direct ownership by 3% to 1,046,141 units (SEC Form 4)

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    3/10/26 6:16:09 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by SentinelOne Inc.

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    3/10/26 6:08:24 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    SEC Filings

    View All

    SEC Form 8-K filed by Aclaris Therapeutics Inc.

    8-K - Aclaris Therapeutics, Inc. (0001557746) (Filer)

    3/11/26 4:30:11 PM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.

    6-K - NeuroSense Therapeutics Ltd. (0001875091) (Filer)

    3/11/26 8:00:07 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Yext Inc.

    S-8 - Yext, Inc. (0001614178) (Filer)

    3/10/26 4:10:10 PM ET
    $YEXT
    EDP Services
    Technology

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Yext downgraded by Roth Capital with a new price target

    Roth Capital downgraded Yext from Buy to Neutral and set a new price target of $6.00

    3/11/26 8:31:24 AM ET
    $YEXT
    EDP Services
    Technology

    Wells Fargo initiated coverage on SentinelOne with a new price target

    Wells Fargo initiated coverage of SentinelOne with a rating of Equal Weight and set a new price target of $13.00

    3/3/26 8:30:47 AM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Asana upgraded by Citigroup with a new price target

    Citigroup upgraded Asana from Neutral to Buy and set a new price target of $16.00

    1/15/26 8:27:19 AM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    12/29/25 8:10:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Peek Mark S bought $595,600 worth of shares (40,000 units at $14.89) (SEC Form 4)

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    12/18/25 5:49:46 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT

    The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com KING OF PRUSSIA, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on March 12th, 2026. Mr. Bitterman

    3/10/26 7:59:39 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT

    The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.comKing of Prussia, Pennsylvania--(Newsfile Corp. - March 10, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on March 12th, 2026. Mr. Bit

    3/10/26 7:00:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Leadership Updates

    Live Leadership Updates

    View All

    SentinelOne Appoints Sonalee Parekh as Chief Financial Officer

    World's leading AI security firm ushers in next chapter of growth and profitability with new CFO SentinelOne (NYSE:S), the leader in AI-native cybersecurity, today announced the appointment of Sonalee Parekh as Chief Financial Officer, effective March 24, 2026. Ms. Parekh will oversee all aspects of the company's global financial operations, including FP&A, accounting, tax and treasury, internal audit, and investor relations. Barry Padgett will continue to serve as Interim CFO until Ms. Parekh's start date, leading the company's upcoming fiscal fourth quarter and full year 2026 earnings report and ensuring a seamless transition. Bringing more than 25 years of experience across public so

    3/3/26 4:05:00 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Asana to Appoint Aziz Megji to the Role of Chief Financial Officer

    Asana, Inc. (NYSE:ASAN)(LTSE: ASAN), the system of action where humans and AI run work together, will promote Aziz Megji to the role of Chief Financial Officer (CFO), effective March 24, 2026. Megji will succeed Sonalee Parekh, who has served as Asana's CFO since 2024 and tendered her resignation effective March 23, 2026. Megji brings his experience from his Head of Financial Planning & Analysis role where he led the company's annual planning, budgeting, forecasting, and performance management processes, as well as overseeing the strategic finance, treasury, investor relations, corporate development, deal desk, and sales compensation functions. He partners closely with Asana's CEO and Boa

    3/2/26 4:06:00 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Financials

    Live finance-specific insights

    View All

    Box Reports Fourth Quarter and Fiscal 2026 Financial Results

    Fourth Quarter Revenue of $306 Million and Fiscal 2026 Revenue of $1.18 Billion Fourth Quarter Remaining Performance Obligations of $1.7 Billion, up 17% Year-Over-Year, up 16% in Constant Currency Fourth Quarter GAAP Operating Margin of 10.2% and Non-GAAP Operating Margin of 30.6% Fourth Quarter GAAP Net Income Per Share of $0.47 and Non-GAAP Net Income Per Share of $0.49 Box, Inc. (NYSE:BOX), the leading Intelligent Content Management ("ICM") platform, today announced preliminary financial results for the fourth quarter and fiscal year 2026, which ended January 31, 2026. "Fiscal 2026 was a defining year for Box, as we executed on the launch of Enterprise Advanced, delivering cust

    3/3/26 4:05:00 PM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    Asana Announces Fourth Quarter and Fiscal Year 2026 Results

    Delivered Q4 revenue of $205.6 million, up 9% year over year Expanded Q4 GAAP operating margin by over 17 percentage points and non-GAAP operating margin by 10 percentage points Grew Q4 operating cash flow by 74% and adjusted free cash flow by 108% year over year Board authorized an additional $160M for share repurchases, bringing total authorization available to approximately $200M Asana, Inc. (NYSE:ASAN) (LTSE: ASAN), the system of action where humans and AI run work together, today reported financial results for its fourth quarter and fiscal year ended January 31, 2026. "FY26 was a year of meaningful progress as we advanced Asana into a multi-product platform and strengthened our pos

    3/2/26 4:05:00 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    - Positive Interim Results of Phase 1a Single (SAD) and Multiple Ascending Dose (MAD) Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Support Rapid Clinical Advancement; Complete Top Line Results Expected in the Second Quarter of 2026 - - Phase 1b Proof-of-Concept Trials of ATI-052 in Atopic Dermatitis (AD) and Asthma Underway; Top Line Results from Both Trials Anticipated in the Second Half of 2026 - - Investigational New Drug (IND) Application for Lead ITK Inhibitor Candidate ATI-9494 Expected in the SecondHalf of 2026 - - ATI-2138, Aclaris' Investigational Inhibitor of ITK and JAK3, Demonstrated Potential Best-in-Class Hair Regrowth in Murine Alopecia Model -  WAYNE, Pa., Feb. 26,

    2/26/26 6:58:00 AM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRS
    $ALLR
    $ASAN
    $ASPN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Aclaris Therapeutics Inc.

    SC 13G - Aclaris Therapeutics, Inc. (0001557746) (Subject)

    11/25/24 11:02:19 AM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care